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Background: Fungi are important pathogens but challenging to enumerate using next-generation sequencing
because of low absolute abundance in many samples and high levels of fungal DNA from contaminating sources.
Results: Here, we analyze fungal lineages present in the human airway using an improved method for contamination
filtering. We use DNA quantification data, which are routinely acquired during DNA library preparation, to annotate
output sequence data, and improve the identification and filtering of contaminants. We compare fungal communities
and bacterial communities from healthy subjects, HIV+ subjects, and lung transplant recipients, providing a gradient of
increasing lung impairment for comparison. We use deep sequencing to characterize ribosomal rRNA gene segments
from fungi and bacteria in DNA extracted from bronchiolar lavage samples and oropharyngeal wash. Comparison to
clinical culture data documents improved detection after applying the filtering procedure.
Conclusions: We find increased representation of medically relevant organisms, including Candida, Cryptococcus, and
Aspergillus, in subjects with increasingly severe pulmonary and immunologic deficits. We analyze covariation of fungal
and bacterial taxa, and find that oropharyngeal communities rich in Candida are also rich in mitis group Streptococci,
a community pattern associated with pathogenic polymicrobial biofilms. Thus, using this approach, it is possible to
characterize fungal communities in the human respiratory tract more accurately and explore their interactions with
bacterial communities in health and disease.Background
Next-generation sequencing can provide unprecedented
data on the composition of mixed microbial communities,
including those important in clinical infections, but ad-
mixture of contaminating DNAs into low biomass samples
provides a considerable challenge to analysis. For example,
fungi can result in both colonization and severe infections
of the human airway, but are often present in environmen-
tal specimens in low abundance, complicating distinguish-
ing authentic community members from background.* Correspondence: collmanr@mail.med.upenn.edu;
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unless otherwise stated.Here we introduce a method for abundance-weighting
that improves detection of fungi, and use the method to:
(1) identify fungi in clinical airway samples; and (2) quan-
tify covariation of fungal and bacterial lineages.
Many examples of medically important interactions be-
tween individual bacteria and fungi have been reported
[1-4]. For example, the fungus Candida albicans is known
to interact with several bacteria in disease states, including
with Pseudomonas in wound infections, with Staphylococci
in systemic infections, and with Streptococci in dental car-
ies. However, fungal-bacterial interactions have not been
studied extensively using culture-independent sequence-
based methods (for a few examples see [5-9]).
Here we compare a series of samples from the airway of
subjects with progressively more severe immunodeficiency
and/or lung disease, consisting of healthy controls, HIV+
subjects, subjects with mixed pulmonary diseases, andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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treatment with immunosuppressive drugs, and mechanical
defense mechanisms are also compromised due to defect-
ive cough reflex from vagal denervation, mucociliary clear-
ance dysfunction, and anastomotic site barriers [10-19].
The HIV+ subjects included individuals both on and off
antiretroviral therapy, but most had relatively preserved
immune function based on CD4 T cell counts, providing a
group intermediate between healthy controls and lung
transplant recipients.
In previous studies, we investigated the microbiota of
the healthy lung [20] and of the lung allograft from lung
transplantation subjects [21], using samples obtained by
bronchoalveolar lavage (BAL). Upper respiratory com-
munities were sampled concurrently by oropharyngeal
wash (OW). We used targeted PCR amplification of 16S
rDNA sequence tags to characterize bacteria and ITS1
rDNA sequence tags to characterize fungi. In healthy sub-
jects, bacterial communities in lung are quite sparse, and
dominated by lineages from the densely colonized upper
respiratory tract (URT). Oropharyngeal lineages in BAL
may be authentically present as a result of aspiration, but
may also be introduced into BAL samples as contaminants
during trans-oral bronchoscopy [20]. In lung transplant
recipients, however, the lung allograft contains a higher
microbial biomass, and BAL samples contain a greater
proportion of distinctive lineages likely representing bac-
teria authentically replicating in lung [21]. BAL samples
from individual transplant recipients commonly showed
high levels of specific bacterial taxa including Pseudo-
monas [22], Staphylococcus [23], or Achromobacter [24],
as well as the little known anaerobic lineage Sneathia [25].
The HIV+ subjects studied here had relatively preserved
immune function, and levels of bacterial DNA were com-
parable to healthy controls.
A significant problem in sampling fungi is the relatively
modest numbers of organisms in typical samples and the
high representation of contaminating lineages in blank
controls, reflecting admixture of fungal DNA from envir-
onmental sources during sample acquisition or DNA con-
tamination in reagents. Here we introduce a method for
using information on the efficiency of PCR reactions
(PicoGreen quantification prior to amplicon pooling) to
improve detection of authentically present fungi. An ad-
vantage of this approach is that sequencing laboratories
necessarily collect the PicoGreen data as a step in se-
quence library preparation, so acquisition of these data re-
quires no extra effort. Using the corrected abundances, we
queried the data from healthy subjects, HIV+ subjects,
and lung transplant recipients for evidence of authentic
respiratory tract fungi, and for covariation of bacterial
and fungal lineages. We: (1) identified multiple lineages
of clinical interest enriched in the more immunocom-
promised subjects; and (2) found a significant covariationof Candida and Streptococcus, an interaction which has
been proposed to be important in formation of medically
important biofilms [26], and which we characterize in
more detail here.
Results
Fungal diversity and community composition
Samples were obtained from healthy control subjects (n =
12), HIV+ subjects (n = 19), subjects undergoing bron-
choscopy for a variety of clinical indications (n = 13), and
lung transplant recipients (n = 42). Healthy and HIV+
subjects were without respiratory symptoms and had not
used recent antibiotics. HIV+ subjects included untreated
viremic (n = 11) and antiretroviral-treated, virologically-
suppressed individuals (n = 8), with median CD4 T cell
counts of 591 and 674, respectively. Lung transplant sub-
jects were all undergoing treatment with multiple immuno-
suppressive drugs and combinations of antibiotics. The
study groups and sampling protocols are listed in Table 1
and Additional file 1.
We profiled the fungal populations of 69 oropharyngeal
wash and 149 BAL samples using 454 pyrosequencing of
rRNA ITS regions. The bacterial community composition
was also characterized by amplifying and sequencing 16 s
rRNA V1V2 regions (data for healthy subjects in group
2B and transplant recipients with paired BAL and
OW samples was published previously [20,21], data
for HIV+ subjects is new here). A set of 132 contamin-
ation control samples were also analyzed to enumerate the
fungal DNA present in lab water (21 samples), saline solu-
tion used for OW and BAL sampling (9 samples), within
the suction channel of a bronchoscope (86 samples), sterile
swabs (8 samples), and lab tabletop surfaces (8 samples).
The sources of contamination control samples are more
fully described in Additional file 2. Analysis of contamin-
ation in 16S data is described in [20].
We recovered a median value of 798 ITS reads per sam-
ple after removal of low-quality reads. The number of
reads per sample is somewhat low for deep sequencing
studies, but as discussed below relatively few fungi are typ-
ically present in samples, so the read numbers are gener-
ally adequate for detection, as seen in earlier studies [21].
The number of reads per sample was significantly lower
in contamination control samples compared to BAL/OW
samples (Mann–Whitney test, P <0.001). After clustering
at 97% similarity, we obtained a total of 1801 fungal oper-
ational taxonomic units (OTUs). Following taxonomic
assignment, we identified 153 OTUs arising from non-
fungal sources, including human, plants, and bacteria.
Additionally, we flagged 77 OTUs as potential chimeras.
These were removed prior to subsequent analysis.
Figure 1 shows a representative heatmap of fungal pro-
portions for all non-transplant samples in the study (data
for transplant samples are in [21]). A total of 61 fungal
Table 1 Groups of subjects appearing in this study
Group Subjects (n) Description Median CD4 count Bronchoscopy procedure Reference
1A 8 HIV+ off ART, CD4 > 400 769 Two scope This study
1B 3 HIV+ off ART, CD4 < 400 315 Two scope This study
2B 8 HIV+ on ART, no lung disease 674 Two scope This study
3B 6 HIV-, no lung disease Two scope 16S data [20], ITS data [21]
3C 4 HIV-, no lung disease None This study
3D 6a HIV-, no lung disease Single scope This study
Pulm 13 HIV-, mixed lung disease Single scope This study
Transplant 42 Lung transplant recipients Single scope Time points with paired BAL
and OW samples [21]b
aFour subjects in group 3D were also sampled in group 3B. In each case, the group 3D sample was taken more than 1 year after the 3B sample (see Additional file 1
for details).
bSample sets Tx34B and Tx41B appear as Tx34 and Tx41, respectively, in Charlson 2012. The initial time points were not included in the previous publication
because OW samples were not collected at the time of sampling.
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reads counting across all samples in this set. The genus
could be assigned for 65% of the OTUs, 83% could be
assigned at the class level, and 90% at the phylum level.
Although the total number of fungal OTUs detected is
large, the number of OTUs present in any one sample is
low. At a sequencing depth of 300 reads, the average rich-
ness or number of OTUs detected in each OW/BAL sam-
ple is only 14. In contrast, bacterial communities from
similar samples have a richness of about 130 OTUs at
the same sequencing depth. The number of abundant
fungal OTUs is also low, as indicated by the sum of the






Figure 1 Proportional abundance of fungal genera in oropharyngeal
samples. Many genera with high proportional abundance appear in only a
or 10 BAL samples are identified by name (full data in Additional file 2).diversity was only weakly dependent on the total num-
ber of reads (Additional file 2), and had a mean value of
1.5 for the fungal communities in oropharyngeal and BAL
samples. Comparable bacterial communities have a Shan-
non diversity of 3 to 4 [21].
Disturbingly, the composition of fungi in BAL samples
was generally similar to that in contamination controls
(Figure 1, right side). A PERMANOVA test of pairwise
Jaccard or Bray-Curtis distances yielded no significant
difference between BAL and contamination control samples
in healthy subjects (Additional file 2) [27]. The oropharyn-
geal wash samples were distinguishable from contamin-































wash, bronchoalveolar lavage, and contamination control
few samples. For simplicity, only genera that were detected in 10 OW
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Candida for the oropharyngeal region [28]. Thus it is diffi-
cult to determine whether any given detection of fungal
DNA in a specific sample represents authentic presence of
the organism or contamination.
A further problem is that the reproducibility of fungal
proportions measured in oropharyngeal and BAL sam-
ples is poor between repeat extractions from the same
source. To examine this, we carried out repeated DNA
extractions and ITS sequencing for bronchoscope pre-
wash, OW, and BAL samples from six subjects in the
Pulm and Transplant groups. In two OW and two BAL
samples, a fungal OTU was observed with over 50% pro-
portion in one replicate, but was absent from another
(Additional file 2). Fungal OTUs with proportions of 1%
to 50% in general appeared sporadically between replicates
(further details in Additional file 2). Bacterial proportions,
by contrast, are recovered with reasonable accuracy down
to proportions of 10−4 for comparable sample types [29].
The poor reproducibility of fungal proportions would be
expected for stochastic sampling of low abundance taxa
derived from a combination of contaminants and authen-
tically present lineages.
Use of DNA quantification after ITS PCR for improved
accuracy
We investigated whether absolute abundance measure-
ments could be used to supplement the relative abun-
dance data from pyrosequencing and address some of the
above problems. Fungal quantification by qPCR primers
directed at the 18S rRNA gene was impossible because
the overwhelming proportion of human DNA in BAL
and OW samples resulted primarily in amplification of
human 18S DNA, even with fungal-targeted 18S primers
(data not shown). We thus quantified fungal DNA using
the ITS-specific primers used in preparing pyrosequenc-
ing libraries.
To quantify fungal templates present in a sample, we
took advantage of DNA quantification data generated dur-
ing routine preparation of sequencing libraries. In a typical
experiment, individual airway DNA specimens are ampli-
fied by PCR using ITS primers, DNA products purified,
and the PCR yield quantified using the PicoGreen dye-
binding assay. Equal amounts of DNA from each sample
are then pooled and introduced into the sequencing in-
strument. Here we used the post-PCR PicoGreen data to
estimate the number of ITS templates present in the initial
DNA sample prior to PCR, which could then be used to
annotate the sequence proportions, yielding estimates
of OTU abundance that take account of template abun-
dance in the original airway DNA specimen. It would be
possible to substitute ITS QPCR at this step with im-
proved accuracy, but fungal ITS sequences are of variable
lengths, complicating quantification, and we sought toexplore what was possible using PicoGreen data on end
point PCR because of the ready availability.
To evaluate PicoGreen quantification, we first quanti-
fied PCR product formation when dilutions of S. cerevi-
siae genomic DNA were used as amplification template
(Figure 2A). Above 100 ng/μL of ITS amplicon, the
PicoGreen assay was saturated. However, below values
of 60 ng/μL, the response of the PicoGreen assay was
linear with the number of input genomes (R2 = 0.98),
suggesting that post-PCR ITS PicoGreen values report
the amount of starting ITS templates within this range.
We next tested oropharyngeal wash samples containing
biologically relevant fungal communities. Serial dilutions
were performed for OW samples from two transplant
subjects, followed by amplification and PicoGreen quanti-
fication. The samples were selected for study because they
yielded levels of ITS product in prior analysis that were
among the highest of any of our respiratory tract samples,
suggesting authentic detection of fungi and allowing us to
dilute through a broad range of concentrations [21]. The
relationship between OW input and PicoGreen-quantified
ITS product was linear in the expected range of 0 to
60 ng/μL (R2 > 0.97 for both samples, Figure 2B). We also
measured the post-PCR ITS DNA concentration in OW
samples after spiking in DNA from S. cerevisiae. As ex-
pected, the PicoGreen quantification was linear at concen-
trations below 60 ng/μL (R2 > 0.99, Figure 2C). Thus the
ITS PicoGreen quantification is linear across a range that
would be present in many respiratory tract samples.
Quantification of ITS PCR product generated by
amplifying OW, BAL, and contamination control samples
The median amount of ITS DNA produced by PCR was
different for OW, BAL, and contamination control sam-
ples (Figure 2C, P <0.001, Kruskal-Wallis). The median
for oropharyngeal wash samples was 5.6 ng/μL compared
to 1.3 ng/μL for BAL samples (P <0.001, Mann–Whitney).
The median ITS PCR product of contamination control
samples, 0.69 ng/μL, was smaller than that of BAL and
oropharyngeal wash samples (P <0.001, Mann–Whitney).
Although significantly smaller, the concentration of fungal
ITS DNA in contamination controls was within an order
of magnitude for OW and within a factor of 4 for BAL
samples. Thus a substantial fraction of ITS reads in the
experimental samples likely arose from contamination
sources.
Analysis of PicoGreen-corrected OTU abundances
We next used the abundance data from PicoGreen quanti-
fication to transform the relative proportions determined
from the pyrosequencing data. The corrected abundance
of each OTU was computed by multiplying the total post-
PCR ITS DNA concentration for the sample by the pro-
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Figure 2 Quantification of post-PCR ITS DNA is linear in the range of oropharyngeal, lung, and contamination control samples. (A) Two
serial dilutions of a standard sample of S. cerevisiae showed a linear response between input and post-PCR PicoGreen-quantification in the range
yielding 0 to 60 ng/μL of ITS product. (B) Serial dilutions of two oropharyngeal wash samples from lung transplant recipients also showed a linear
response in this range. (C) Genomic DNA from S. cerevisiae spiked into an oropharyngeal wash sample resulted in a linear increase in total DNA
concentration within the 0 to 60 ng/μL range, as measured by post-PCR PicoGreen quantification. (D) Although the total concentration of post-PCR
ITS DNA differed between sample types, the median concentration of contamination control samples was about 10% of the concentration in
oropharyngeal wash. The median concentration of lung samples was only a few times that of contamination controls.
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cumulative distribution function was generated from the
PicoGreen-corrected OTU abundances in contamination
control samples. A histogram of the abundance distribu-
tion in contamination controls is shown in Figure 3A.
The 95% limit of the abundance distribution for con-
trol samples was 0.3 ng/μL. An inset plot shows the
control OTUs with abundance above the 95% limit.
No single contamination source dominated this set of
high-abundance OTUs.
A 95% confidence threshold for abundance is somewhat
conservative. We judged it to be suitable for the set of
samples presented here, where we are interested in de-
scribing the set of fungi that are unlikely to arise from
contamination sources. For other applications, a different
threshold may be used simply by selecting a differentpercentile value from the distribution of OTU abundances
in contamination samples.
A potential issue with the use of a global abundance
threshold is that the abundance distribution of some fun-
gal genera may differ from the global distribution. To
check this, we selected all fungal genera appearing in 10
or more contamination control samples and estimated a
genus-specific abundance threshold. In every case save
one, the global abundance threshold fell within the 95%
confidence limits of the genus-specific threshold, indicat-
ing that the genus-specific thresholds are compatible with
the global threshold. The sole exception is Cladosporium,
the most commonly occurring fungal genus in contam-
ination control samples. We estimated a genus-specific
threshold of 0.81, about three times higher than the global
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Figure 3 A global threshold for PicoGreen-corrected OTU abundance identifies genera in experimental samples that are extremely
unlikely to arise from contamination sources. (A) Histogram of PicoGreen-corrected OTU abundances in control samples. The inset plot shows
abundances above the 95% limit of the distribution, colored by contamination sample type. (B) Agreement between the PicoGreen-corrected
abundance of fungi computed from ITS sequencing and clinical culture results in BAL samples. (C) ROC curve of post-PCR ITS abundance vs.
culture results for all cultured fungi. The sequencing method is a good predictor of culture results (AUC = 0.93).
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arise from contamination sources.
Application of PicoGreen-corrected OTU abundances to
clinical samples
To verify that a global abundance threshold would work
as intended, we first applied the global abundance thresh-
old technique to a set of 47 BAL samples for which we
had clinical culture results. The samples came from lung
transplant recipients who are heavily immunosuppressed
and highly susceptible to fungal colonization and infec-
tion. BAL samples were cultured using standard clinical
methods. Cultures from 18 samples were positive for fungi
including Candida albicans, Aspergillus flavus, A. fumigatus,
and Purpureocillium lilacinum (syn. Paecilomyces lilacinus).
After matching the OTU assignments to the cultured spe-
cies, we recovered 14 of 20 positive culture results with
our method (Figure 3B). Of the remaining six, two sam-
ples revealed Aspergillus by both ITS and culture but dif-
fered in the species identified (A. fumigatus by culture and
A. flavus by ITS assignment in sample 44, and vice versain sample 36A). In samples Tx6, Tx35, and Tx44, we de-
tected the cultured fungus by sequencing (A. flavus in
Tx6, C. albicans in Tx35, A. fumigatus and P. lilacinum
in Tx44), but the PicoGreen-corrected quantity was
below the contamination threshold. Sample Tx5 cultured
positive for C. albicans, but we detected high levels of
C. dubliniensis, a closely related species that is often not
distinguished from C. albicans in culture [30]. We counted
this as a positive result. Our method also identified four
samples with high concentrations of C. albicans DNA that
were not detected by culture.
We evaluated our ITS fungal detection method across
all possible threshold values by plotting the receiver
operating characteristic (ROC) curve, which displays the
rate of true positives (from culture results) against the rate
of false positives (Figure 3C). The area under the curve
was 0.93, indicating that our method was able to de-
tect most culture positive fungi with few false posi-
tives. We also assessed the consistency between culture
and sequencing results using Cohen’s Kappa coeffi-
cient, which measures the level of agreement above
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culture results had a Kappa of 0.65, indicating good
agreement. This level of agreement is slightly higher
than those reported in a study of bacterial culture vs.
DNA sequencing methods [31]. The value of Kappa
was not sensitive to the abundance threshold used
(Additional file 2).
Returning to the issue of reproducibility, we re-evaluated
our set of replicate samples using PicoGreen-corrected
abundances. We found that use of an absolute abundance
threshold improved the level of agreement between repli-
cate samples extracted from the same source material,
especially when the PicoGreen-corrected abundance is




































































































































































































































































Figure 4 Heatmap of fungal genera identified in a matched set of oropIdentifying fungi in oropharyngeal and BAL samples that
were unlikely to originate from contamination
We next applied a global abundance threshold to the
OW and BAL samples from subjects in our study.
Using our abundance threshold approach, we elimi-
nated OTUs in each sample with PicoGreen-corrected
abundance <0.3 ng/μL. The remaining OTUs, shown in
Figure 4, are unlikely to arise from contamination sources.
A more detailed set of plots is available in Additional
file 2.
We identified Candida in an OW sample of approxi-
mately half of the healthy individuals in the study (samples
3D03-3D06 are repeat samples from individuals in group







































































































































































haryngeal and lung samples following curation by ITS abundance.
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http://genomebiology.com/2014/15/10/487BAL samples from healthy individuals. The fungi identi-
fied in BAL samples from healthy subjects were taxa of lit-
tle clinical importance, with the exception of Aspergillus
in subject 3D05.
The representation of Candida in OW and BAL sam-
ples from HIV+ individuals was similar to that of healthy
subjects, with detection in OW but not BAL, which is
concordant with the frequency of clinical candidiasis in
the upper respiratory tract in this population but rarity of
candidiasis in the lower respiratory tract [32]. HIV+ indi-
viduals are particularly susceptible to pulmonary infection
with fungi (notably Pneumocystis, Cryptococcus, Histoplas-
mosis, and Aspergillus) [33], though the subjects studied
here were without any respiratory symptoms and had rela-
tively well-preserved immune function (mean CD4+ count
644 ± 299). In BAL of HIV+ subjects, we detected clinical
pathogens Pneumocystis, Cryptocossus, and Aspergillus.
One HIV+ subject, 2B02, was found to have high levels of
Microascus in oropharyngeal wash.
Subjects in the Pulm group were sampled while under-
going clinical bronchoscopy for a variety of indications
(details in Additional file 1), and represent a varied as-
sortment of patients with lung disease. Here, we ob-
served Aspergillus in the BAL samples of four subjects,
and Cryptococcus in another. Candida was observed
concurrently in both OW and BAL samples of subjects
Pulm2 and Pulm4.
For lung transplant recipients, also sampled during
clinical bronchoscopy (data in part from [21] and in part
new here), we detected Candida in BAL samples for 14
of the subjects, a significantly higher proportion than in
non-transplant individuals (P <0.001, Fisher’s exact test).
The abundance of Candida in transplant BAL samples
was higher than that observed in the Pulm group, exceed-
ing 20 ng/μL (PCR product measured by PicoGreen) in
five cases (Tx18, Tx38, Tx41A, Tx47, and Tx49). All trans-
plant subjects with Candida in BAL who had OW avail-
able also had Candida in OW, except for one (Tx41B).
Aspergillus was detected in the BAL samples of four trans-
plant subjects, and had an abundance in excess of 20 ng/
μL in samples Tx11A, Tx11B, Tx44. The abundance of
Cryptococcus in transplant BAL samples was similar to
that observed in the Pulm group. Cryptococcus was ob-
served in both OW and BAL for one subject (Tx43).
Fungal occurrence in oropharyngeal and BAL samples
relative to contamination controls
Because so many OTUs were eliminated by the applica-
tion of a global abundance threshold (many of which may
be authentic community members but cannot be defini-
tively distinguished from environmental admixture), we
wondered whether other methods might be able to iden-
tify less abundant genera legitimately present in OW or
BAL samples. For genera where the PicoGreen-correctedabundance is not enough to call individual OTUs as au-
thentically present in a particular sample, the frequency
of occurrence can nevertheless reveal patterns across
sample types. Figure 5 shows the frequency of occurrence
in OW, BAL, and contamination control samples for gen-
era present in at least 10 OW or BAL samples. An ex-
panded plot is included in Additional file 2.
To assess differences in overall frequency of occurrence
between sample types, we used a Fisher’s exact test. If the
sample types were found to be different for a genus,
follow-up tests were performed to determine whether the
rate of occurrence in OW and BAL samples exceeded that
in contamination controls. In each series of tests, we used
the method of Benjamini and Hochberg to control for a
false discovery rate of 5% [34]. Aspergillus, Cladosporium,
Cryptococcus, and Penicillium were present more often
in oropharyngeal wash and BAL samples than in con-
trol samples. Debaryomyces, Fusarium, Malassezia, Pichia,
Rohodotorula, and Saccharomyces appeared more often in
oropharyngeal wash samples than in controls, but did
not occur significantly more often in BAL samples rela-
tive to contamination sources. Pichia was the sole genus
present in more than 10 OW/BAL samples not to appear
in any contamination control samples. The frequencies of
Cystofiloblasidum, Phoma, Talaromyces, Trichosporon, and
Wallemia were about the same in OW, BAL, and contam-
ination control samples.
Fungal covariation with bacteria
To investigate possible interactions in the human respira-
tory tract between microbes from different domains of life,
we investigated covariation between fungi and bacteria in
our samples. For this we used 16S V1V2 tag sequence data
to characterize bacteria from samples used in the analysis
of fungal populations described above. Bacterial 16S rRNA
gene data for group 3B and some of the lung transplant
samples have been published [20,21] (see Table 1 for a
complete listing of data sources). The 16S rRNA tag data
for bacterial communities from HIV+ subjects are newly
presented here. An analysis of the HIV+ 16S rRNA tag
data is presented in Additional file 3. The 16S sample
set included 151 contamination control samples, which
harbored bacterial communities distinct from BAL/OW
samples, as expected [20]. Our analysis showed modest
but statistically significant differences between HIV+ and
healthy controls in OW but not BAL samples. A previ-
ously published study also showed an altered bacterial
microbiome in lingual samples from HIV+ subjects [35],
an oral cavity surface that closely resembles saliva [36].
To assess covariation, we focused on Candida, which
was the most commonly detected fungus in the ITS data
and so provided the power needed for comparison. We an-
alyzed the OW samples and not BAL because a greater















































Figure 5 Presence-absence analysis identifies fungal genera present more often in experimental samples relative to contamination
controls. Aspergillus and Penicillium are present significantly more often in oropharyngeal and lung samples relative to controls, while Pichia and
Saccharomyces are present more often only in OW relative to controls. Conversely, Wallemia likely derives solely from contamination sources.
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of Candida on overall bacterial community composition in
OW. Using an ADONIS test of pairwise UniFrac distances,
we found a significant association of Candida PicoGreen-
corrected abundance with bacterial community compos-
ition (weighted UniFrac P = 0.003, R2 = 0.06; unweighted
UniFrac P = 0.0003, R2 = 0.03). Bacterial communities also
varied significantly in association with high or low abun-
dance of Candida, dividing at the third quartile of Can-
dida abundance (Figure 6A; weighted UniFrac P =0.004,
R2 = 0.05; unweighted UniFrac P = 0.0003, R2 = 0.03).
Previous culture-based studies have suggested that
Candida and Streptococcus are tightly associated in the
human oropharyngeal cavity [26], providing a specific
hypothesis to investigate in the metagenomic data. To
compare the abundance of Candida and Streptococcus,
we multiplied the bacterial OTU proportions by the total
16S DNA abundance obtained by QPCR. The abundance
of Streptococcus increased with that of Candida (Spearman
correlation ρ = 0.41, P <0.001). Figure 6B shows the abun-
dance of Streptococcus in each OW sample after trans-
formation by ranks, plotted against rank-transformed
Candida abundance. We investigated the top 20 most
abundant Streptococcus OTUs to look for trends at the
species level. Allowing for a false discovery rate of 5%, wefound that 10 of the 20 increased with Candida abundance
in a one-sided test of Spearman correlation. Eight were
identified as mitis group Streptococci, and two were identi-
fied as S. salivarius (Additional file 3). One Streptococcus
(S. gordonii, a member of the mitis lineage) showed a posi-
tive association with Candida and was enriched in HIV+
OW samples compared to OW from healthy controls. An
exploratory analysis of effects on other bacteria showed
that Rothia and Veillonella increased significantly with
Candida abundance after controlling for a false discovery
rate of 5%.
Discussion
Microbial community analysis by deep sequencing reports
relative proportions of microbes present in a sample re-
gardless of absolute abundance. Problems arise when sam-
ples contain varying amounts of authentic organisms and a
substantial background of contaminating sequences, as is
commonly the case in respiratory tract samples [20]. Here,
we report that the majority of fungal OTUs observed
in sequence data from OW and BAL samples cannot be
definitively established as authentic sample constituents be-
cause of the admixture of fungal DNA from contaminating
sources. However, OTUs authentically present in ex-
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Figure 6 Bacterial covariation with Candida in OW samples. (A) Principal coordinates analysis of weighted UniFrac distance between
bacterial communities for oropharyngeal wash samples. Group centroids are shown with open triangles. The PicoGreen-corrected abundance
of Candida has a significant effect on bacterial community composition (PERMANOVA P = 0.004, F = 3.8). (B) The QPCR-corrected abundance of
Streptococcus, Rothia, and Veillonella increased with the abundance of Candida (Spearman correlation, P <0.05 after FDR correction). (C) Ten
of the top 20 most abundant Streptococcus OTUs were found to increase with Candida abundance (Spearman correlation, P <0.05 after
FDR correction).
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notate OTU proportions by absolute abundance. This
was validated by comparing OTU calls to clinical cul-
ture results, showing improved correlation after abundance-based correction. Abundance-based correction also greatly
improved agreement between technical replicates from
single samples. Thus, use of an absolute abundance
threshold provides a way to go beyond statistical, population-
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ing identification of specific fungi in a single sample with
known confidence.
Our data show a progression of colonization by clinic-
ally relevant fungi in BAL across the four cohorts, from
the least colonization in healthy controls, through increas-
ing colonization from well suppressed HIV+, to mixed
lung diseases (Pulm), to lung transplant recipients. In the
healthy controls, only low levels of fungal reads were de-
tected, and only one was a candidate for clinically signifi-
cant colonization (Aspergillus). In the HIV+ group, levels
were relatively low, but identification of organisms of clin-
ical importance in BAL was greater (4 out of 18 subjects;
two Aspergillus, one Cryptococcus, and one Pneumocystis).
For the mixed lung disease group (Pulm), fungi appeared
at higher levels in some cases, and organisms of potential
clinical import were detected in seven out of 13 subjects
(four Aspergillus, two Candida, and one Cryptococcus).
For lung transplant recipients, the inferred abundance
levels were far greater in some specimens, and 21 out of
42 individuals showed organisms of potential importance
(4 Aspergillus, 14 Candida, 3 Cryptococcus and 1 Purpur-
eocillium; one sample contained two of these). These data,
together with the positive correlation with clinical diag-
nostic data, support the use of the abundance-weighted
method for identification of fungi of clinical interest.
Although this approach can establish confidence that
an organism is genuinely present in a sample and does
not derive from environmental admixture, it cannot dis-
tinguish possible community mixing, such as upper re-
spiratory admixture with lung samples, which must be
addressed with other measures [20,21].
The fungal sequence data could be analyzed either
by scanning for authentic colonization using the abundance-
weighed method, or by the use of a more sensitive but
more contamination prone presence-absence approach.
The advantage of the presence-absence approach is that
less stringent thresholds can be used for calling enrich-
ment in one sample type over another, allowing more
frequent calling of positive samples. However, given sub-
stantial contamination, one does not know which detec-
tions in experimental samples are authentic and which
represent contaminants. Aspergillus, for example, was
found in over half of the contamination control samples,
but approximately 75% of experimental samples. Thus it
is likely that Aspergillus was authentically present in
many experimental samples, but it is usually not possible
to determine which ones except in those few cases where
levels were particularly high. Using the presence-absence
method, a total of 11 fungal genera were found to be sig-
nificantly more common in either OW or BAL than in
contamination controls.
Several of the fungi studied were enriched in OW sam-
ples but not BAL, which contrasts with findings forbacteria. Published comparisons of bacteria in OW and
BAL in healthy controls showed that communities in the
two body sites were mostly indistinguishable (once the
greater representation of contamination in lung samples
was properly accounted for) [20]. Samples from lung
transplant recipients differed, with many examples of se-
lective bacterial lung colonization [21]. For the fungi stud-
ied here, multiple lineages were notably enriched in OW
compared to BAL, including Candida, Debaryomyces,
Fusarium, Pichia, Rhodotorula, and Saccharomyces,
suggesting more ‘localized’ colonization by these organ-
isms in the oral cavity, possibly reflecting a more surface-
associated lifestyle.
Comparison of abundance-corrected fungal ITS data
and bacterial 16S data enabled us to assess covariation
of the two. Only upper respiratory tract samples had suf-
ficient fungal detection to allow statistical analysis, and
only Candida was sufficiently abundant for study. Previ-
ous literature documents a variety of interactions be-
tween Candida and Streptococci in the mitis group: (1)
S. oralis and S. parasanguinis were reported to grow to-
gether with C. albicans in oral biofilms [26]; (2) S. oralis
was recently shown to enhance the virulence of C. abi-
cans in a mouse model by increasing the mucosal in-
flammatory response [37]; and (3) differences in salivary
flow were reported to change the ratio of Candida to
Streptococcus in the oral cavity [38]. Using the method
of PicoGreen-corrected abundance for fungal species, we
were able to detect association between Candida and
bacteria in the S. mitis group in our deep sequencing
data. We also found linkage between Candida and an-
other Streptococcus species outside of the mitis group, S.
salivarius. A recent culture-based study observed S. sali-
varius-C. albicans association and found that S. salivarius
may interfere with the ability of C. albicans to adhere to
surfaces, thereby reducing the potential for development
of candidiasis [39]. One Streptococcus lineage was found
to be both enriched in OW in HIV+ versus healthy con-
trols and positively associated with Candida, suggesting
a possible specific interaction in the setting of HIV infec-
tion. We also found that Rothia and Veillonella covaried
with Candida at the genus level, helping to specify a
larger community pattern associated with high Candida
abundance.
Conclusions
The abundance-weighted sequence-based approach has
several advantages compared to traditional culture based
methods used in clinical diagnosis. The sequence-based
method provides an overview of all community mem-
bers in a single assay, without any requirement for assay-
ing organisms individually. The abundance-weighted
sequence-based method is potentially quite rapid given
sufficient optimization at each analytical step, though
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use this approach, every laboratory must establish its
own empirical contamination control threshold, since
the efficiency of amplification will be affected by many
laboratory-specific variables. Thus for these and other
reasons collection of extensive contamination control
data is essential. These data taken together indicate
that the use of abundance-weighted sequence-based




Subjects studied are enumerated in Table 1 and Additional
file 1. Healthy volunteers and asymptomatic HIV+ sub-
jects who were without lung disease, acute respiratory
symptoms, or recent antibiotic use underwent upper re-
spiratory tract sampling by oropharyngeal wash (OW)
followed by bronchoscopy with bronchoalveolar lavage
(BAL). Sampling of healthy subjects has been previ-
ously described [20], and HIV+ volunteers were sam-
pled in an identical manner. For subjects where multiple
BAL samples were available [20], the BAL A second
return sample was used. Healthy volunteers in group
3C were sampled by OW only. Healthy volunteers in
group 3D were sampled in the same manner as other
healthy subjects [20], but a single bronchoscope was used
for the procedure. Lung transplant recipients routinely
undergo surveillance bronchoscopy and BAL, and a por-
tion of clinical BAL fluid as well as OW obtained immedi-
ately prior to bronchoscopy were collected as described
[21]. Subjects in the Pulm group were sampled during
clinically-indicated bronchoscopies in the same manner
as lung transplant subjects. Environmental contamin-
ation controls included sterile saline used for OW and
BAL sampling, saline washed through the channel of ster-
ile bronchoscopes, and lab water mock-purified as previ-
ously described [20,21].
Written informed consent was granted by all subjects
in the study. Protocols were approved by the Institutional
Review Board of the University of Pennsylvania (protocols
#810501 and 812748).
454 sequencing
To profile fungal communities, genomic DNA was ex-
tracted from whole neat BAL or OW using the Power-
Soil DNA isolation kit (MoBio, Carlsbad, CA, USA) as
previously described [40]. ITS genes were amplified in
triplicate using barcoded ITS1F/ITS2 primers [40]. ITS
amplicons were purified using Agencourt AmPure XP
beads (Beckman-Colter, Brea, CA, USA) to remove primer
dimers and short amplicons before PicoGreen quantifica-
tion. Following this, 454 pyrosequencing was performed
as previously described [40].Absolute DNA quantification
A PicoGreen assay was used to quantify all PCR products
prior pooling for pyrosequencing. Following the protocols
for DNA extraction and PCR amplification [40], 10 uL of
PCR product was used for the quantification.
To determine the relationship between fungal DNA con-
centration in PCR reactions and PicoGreen fluorescence
measured on PCR products, we assayed a dilution series
of S. cerevisiae genomic DNA where each dilution was
PCR amplified in triplicate and quantified with PicoGreen.
The starting concentration of S. cerevisiae genomic
DNA was 0.625 ng/μL, as measured by PicoGreen. Dilu-
tions from the stock concentration were made in steps
of 1:2, down to a 1:1,024 dilution. Following that, a
1:10 dilution series was made from 1:10 k to 1:1 M.
Each dilution was PCR amplified in triplicate using
Accuprime PCR reagents and the ITS primer pair de-
scribed above. The resulting PCR products were quanti-
fied using PicoGreen at a 1:100 dilution. Two such
dilution series were made to examine reproducibility.
We then chose two oropharyngeal wash samples that
contained high levels of ITS amplicon by PicoGreen
and followed the same protocol for serial dilution and
PCR amplification for each dilution. The resulting PCR
products were quantified using PicoGreen at a 1:20
or 1:50 dilution. We also conducted a spiking experi-
ment where increasing amounts of purified S. cerevi-
siae genomic DNA were added to an oropharyngeal
wash sample.
Bioinformatic analysis
Bioinformatic analysis of sequence tag data was carried
out using the QIIME pipeline ver. 1.8 [41], followed by
statistical analysis in the R programming language [42].
For the ITS amplicon, reads were filtered to remove
sequences shorter than 130 bp, sequences with a homo-
polymer run exceeding 6 bp, and sequences with more
than two ambiguous base calls (Ns). To be included in
the analysis, reads were also required to match the
sample-specific barcode sequence and the leading ITS
primer sequence exactly. The reads were clustered by
similarity at the 97% level using UCLUST [43]. Taxo-
nomic assignments were generated by BROCC [40], after
BLASTing representative ITS sequences to the nt data-
base from NCBI (maximum e-value of 10−5, maximum
100 results per query).
For the 16S amplicon, reads were similarly filtered, but
a minimum length of 200 bp was required. Taxonomic
assignments were generated with the UCLUST-based
consensus assignment method in QIIME ver. 1.8, using
the GreenGenes taxonomy rev. 13_8 [44,45]. To compute
pairwise UniFrac distances, the 16S reads were aligned
with PyNAST [46] and a phylogenetic tree was estimated
with FastTree 2 [47].
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